Mark G. Foletta
Director · DEXCOM INC
IndividualSelling only6 10b5-1 trades
- 2025
- Aug 4, 2026
- 13
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark G. Foletta files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin R. Sayer - $8.30M in DXCM purchases and sales in the last 12 months
- Jacob Steven Leach - $1.00M in DXCM purchases and sales in the last 12 months
- Michael Jon Brown - $873K in DXCM purchases and sales in the last 12 months
- Jon Coleman - $723K in DXCM purchases and sales in the last 12 months
- Nicholas Augustinos - $680K in DXCM purchases and sales in the last 12 months
- Sadie Stern - $448K in DXCM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark G. Foletta?
Mark G. Foletta is a corporate insider, tracked as Director of DEXCOM INC (DXCM). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark G. Foletta submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Mark G. Foletta been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($1.43M) across all tracked filings.
